Sign in
Not yet taking people in United StatesNo phase

EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients

Key facts

Who runs it
Columbia University
Where
New York, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
600 people, planned
Started
1 Apr 2026
Expected to end
31 Mar 2031
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Alpha Optimization
  • Emergence from anesthesia with Dexmedetomidine
Record updated
7 January 2026

Who can take part

Age
60 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adults aged 60 years or over
  • Has capacity to provide informed consent
  • Undergoing elective non-cardiac surgery, which does not involve the head or neck, with planned volatile-based general anesthesia of expected duration of at least 2 hours

Who cannot take part

  • Chronic pain with opioid requirement or concurrent use of enzyme inducers, e.g. carbamazepine, phenytoin,
  • Illicit substance use or excessive alcohol intake
  • Refusal by patient or case anesthesiologist responsible for patient's care

Where in United States

  • Columbia University Irving Medical CenterNew York, United StatesContact: Paul S. Garcia, MD, PhDNot yet recruiting

About the trial

What the trial wants to find out

The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.

The 4 groups in the trial

  • Maintenance-Alpha Optimization / Wake from DexmedetomidineTreatment being tested

    During the first randomization, participants randomized to intraoperative oscillatory EEG alpha optimization will receive individualized titration of anesthetic gas and opioids.

    Treatment: Alpha Optimization and Emergence from anesthesia with Dexmedetomidine

  • Maintenance-Alpha Optimization / Wake from SevofluraneExisting treatment, for comparison

    During the first randomization, participants randomized to intraoperative oscillatory EEG alpha optimization will receive real-time monitoring of alpha recordings and individualized titration of desflurane and opioid. During the second randomization, participants randomized to standard emergence from volatile anesthesia will be woken up per standard practice.

    Treatment: Alpha Optimization

  • Maintenance-Routine Care / Wake from DexmedetomidineExisting treatment, for comparison

    During the first randomization, participants randomized to standard of care will receive anesthesia per usual care with quantitative processed EEG index values and EEG wave forms.

    Treatment: Emergence from anesthesia with Dexmedetomidine

  • Maintenance-Routine Care / Wake from SevofluraneNo study treatment, for comparison

    During the first randomization, participants randomized to standard of care will receive anesthesia per usual care with quantitative processed EEG index values and EEG wave forms. During the second randomization, participants randomized to standard emergence from volatile anesthesia will be woken up per standard practice.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
7 January 2026